Navigation Links
High-dose fluticasone effective against eosinophilic esophagitis
Date:7/18/2014

and 93 percent remained in complete or partial remission. Participants who did not respond to fluticasone during the first three months received 1760-microgram doses for three more months, but remained largely unresponsive to the drug. The findings suggest that approximately 25 percent of people with EoE do not respond to steroid treatment.

The scientists also evaluated gene expression in esophageal tissue samples. They found that the gene expression signatures of participants who went into remission changed substantially, becoming similar but not identical to those of healthy people. The changes in signatures of participants who did not respond to fluticasone were small, suggesting that these participants were resistant to the drug. The investigators identified 15 genes that may be useful in identifying patients who will respond to steroid treatment, but further studies are needed to confirm this finding.


'/>"/>
Contact: Hillary Hoffman
hillary.hoffman@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Predicting outcome for high-dose IL-2 therapy in cancer patients
2. Reducing Unnecessary and High-dose Pediatric CT Scans Could Cut Associated Cancers by 62 Percent
3. High-Dose Statins Linked to Acute Kidney Damage
4. High-dose Vorinostat effective at treating relapsed lymphomas
5. Controlling spine metastases with tumor separation surgery and high-dose stereotactic radiosurgery
6. 4 lessons for effective, efficient research in health care settings
7. Depressed men with prostate cancer are diagnosed later stage, get less effective therapies
8. Non-diet approach to weight management more effective in worksite wellness programs
9. R.I. lead law effective, often ignored
10. Drug shows promise for effectively treating metabolic syndrome
11. Biomarker predicts effectiveness of brain cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... The federal court overseeing thousands of vaginal mesh ... District of West Virginia has upheld a $2 million verdict ... trial. In an Order dated January 21st, the Court denied ... C.R. Bard had not proven a miscarriage of justice. (Cisson ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz Chiropractic ... treated just about every type of injury that can result from ... same twenty-plus years, the team at Doctors on Liens ... possible doctor. With the combined breadth of experience between ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
(Date:1/22/2015)... As interest in the value of spiritual support ... Rev. Eric J. Hall , president and CEO of ... be the keynote speaker on January 27 at an international ... , The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual ...
(Date:1/22/2015)... USA (PRWEB) January 22, 2015 State ... statewide data management system with support from GEOSYSTEMS, a ... The new solution will leverage Hexagon Geospatial’s ERDAS ... vector data as well as point clouds and documents. ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... M. Jackson Foundation for the Advancement of Military Medicine, ... anesthesiology residents in the art and science of advanced ... aim is to serve as a resource to manage ... Military Advanced Regional Anesthesia and Analgesia Handbook " is ...
... Net and Elderly Care in Underserved Communities , ... announced today that it has approved more than 400 ... first quarter of 2009. The not-for-profit health care organization,s ... care in the safety net and improving care for ...
... promoting a painless new method for detecting diabetes, ... at the American Association of Clinical Endocrinologists (AACE) ... Texas.(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b ... diabetes, doctors examined the saliva of 40 different ...
... Non Dues Revenue for the Texas Medical ... launched MedBuzz, a powerful new online advertising ... Medical Association that has extended TMA,s online ... generated incremental non-dues revenue for the largest ...
... April 28 MinuteClinic, the pioneer and largest ... States, announced that it has become a participating ... insurer in Pennsylvania based on membership.Members of Highmark,s ... care centers located inside select CVS/pharmacy stores in ...
... SARS, and true severity of outbreak still unknown , , TUESDAY, April ... flu in Mexico rises and new cases appear in the United ... sense of mounting dread. , But experts in influenza and infectious ... still far from certain. , "This is something of concern [but] ...
Cached Medicine News:Health News:HJF publishes handbook on managing pain of battlefield trauma 2Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 2Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 3Health News:Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009 4Health News:Detecting Diabetes Without a Needle: The Spit Factor 2Health News:Audience Generation, LLC Launches MedBuzz for Texas Medical Association 2Health News:Audience Generation, LLC Launches MedBuzz for Texas Medical Association 3Health News:MinuteClinic Becomes Participating Provider With Highmark Inc. 2Health News:MinuteClinic Becomes Participating Provider With Highmark Inc. 3Health News:Experts Say Panic Over Swine Flu Is Premature 2Health News:Experts Say Panic Over Swine Flu Is Premature 3Health News:Experts Say Panic Over Swine Flu Is Premature 4Health News:Experts Say Panic Over Swine Flu Is Premature 5
(Date:1/23/2015)... , Jan. 23, 2015  Now available for sale, The ... support that prevents ankle sprains by cushioning the ankle ... fits securely around the outside of any shoe type ... comfort while still offering protection against sprains. With customers ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
(Date:1/22/2015)...  ViewRay™, a privately held medical device company, announced today ... with ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to ... of cancer in Japan . ViewRay,s ... and only MRI-guided radiation therapy system that images and ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... Finalises Contract to Develop Prototype of the World,s First Ever... -- JERUSALEM, August 31, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up -- STOCKHOLM, August 31, 2010 ... ... ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
Cached Medicine Technology:Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 2Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 3Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 4Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 5Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 6Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 7CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 2CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 3CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 4CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 5CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 6CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 7CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 8CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 9
Iron FS Ferene for determination of iron in serum. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P. For automated systems....
For the quantitative determination of iron, total iron-binding capacity in human serum....
... of HDL-cholesterol in serum and ... immunochemical inhibition of non-HDL-lipoproteins. Excellent ... Endpoint assay. Unaffected by interfering ... Available with calibrator: Trucal HDL/LDL ...
HDL Cholesterol (PEG) Precip. Reagent + 5 ml of 50 mg/dl cholesterol std....
Medicine Products: